Nexobrid Kit
NDC 69866-2005
Product Information
Nexobrid (anacaulase-bcdb) is a BLA-approved product labeled by Vericel Corporation. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a kit for topical administration. This product entry covers the primary NDC 69866-2005 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 69866-2005?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ANACAULASE-BCDB (UNII: JD24M53P9U)
- ANACAULASE-BCDB (UNII: JD24M53P9U) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ACETIC ACID (UNII: Q40Q9N063P)
- AMMONIUM SULFATE (UNII: SU46BAM238)
- WATER (UNII: 059QF0KO0R)
- CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: 4Q93RCW27E)
- SODIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: 22ADO53M6F)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 2626751 - anacaulase-bcdb 8.8 % Topical Gel, 22 GM
- RxCUI: 2626751 - 22000 MG anacaulase-bcdb 0.088 MG/MG Topical Gel
- RxCUI: 2626754 - NexoBrid 8.8 % Topical Gel, 22 GM
- RxCUI: 2626754 - 22000 MG anacaulase-bcdb 0.088 MG/MG Topical Gel [Nexobrid]
- RxCUI: 2626754 - 22000 MG Nexobrid 0.088 MG/MG Topical Gel
* Please review the full disclaimer at the bottom of this page.